This content is machine translated Continuing education series on type 2 diabetes (2022) Module 1: Protecting the kidneys with the right therapy Modern diabetes management also protects the kidneys. In the live webinar on June 16, Prof. Roger Lehmann from the University Hospital Zurich used current study data to explain which therapies… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2022) Module 2: Effectively supporting treatment adherence. Modern therapy for type 2 diabetes brings many benefits to patients – but only if it is followed. Doctor Bá Thanh-Trúc Ngô from Centramed Liestal showed in her live webinar… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2022) Module 3: Multifactorial therapy is the key Addressing all cardio-renal risk factors is worthwhile. In her live webinar on October 27, 2022, Prof. Isabella Sudano from the University Hospital Zurich showed how essential it is to effectively…
View Post 1 min This content is machine translated Program 2022 (2022) Dia-Month Club: Modules at a glance Here you can find the program of the Dia-Month Club 2022:
View Post 5 min This content is machine translated Modern lipid management Treating dyslipidemia in diabetes in a target-oriented manner Diabetes is associated with increased cardiovascular morbidity and mortality. Risk-stratified LDL cholesterol lowering is an important component of diabetes therapy and may improve clinical prognosis. In order to achieve the…
View Post 4 min This content is machine translated Inflammatory rheumatic diseases Targeted therapy in AS and PsA in use for over a year [1]. Ankylosing spondylitis (AS) and psoriatic arthritis (PsA) can cause permanent joint damage and significantly reduce the quality of life of those affected [2, 3]. For more than a year, an…
View Post 7 min This content is machine translated Type 2 diabetes: basal insulin therapy Lower risk of hypoglycemia with second-generation insulin analogues Type 2 diabetes develops insidiously over years and is usually diagnosed in middle to older adulthood – often incidentally during routine checkups. Adequate glycemic control is very important to prevent…
View Post 4 min This content is machine translated Type 2 diabetes and chronic renal failure (CKD) Dapagliflozin: risk reduction even in the presence of greatly increased albumin excretion. About half of all diabetics develop chronic kidney disease. SGLT-2 inhibitors have been shown not only to favorably affect glucose metabolism, but also to protect the heart and kidneys. The…
View Post 4 min This content is machine translated Early treatment of type 2 diabetes New study shows that optimal HbA1c values should be targeted from the time of diagnosis onwards In newly diagnosed type 2 diabetes, the risk of diabetic complications and death can be delayed by many years with the best possible glycemic control. That blood glucose levels early…
View Post 6 min This content is machine translated Management of rheumatoid arthritis “Anyone diagnosed with RA today wants to be completely symptom-free.” With the development of conventional, biologic, and targeted disease-modifying antirheumatic drugs, the prognosis for rheumatoid arthritis has improved significantly since the 1990s. However, many patients still do not respond to…
View Post 2 min This content is machine translated Type 2 diabetes and NAFLD Large waist circumference increases risk of severe liver damage Recent study data suggest an association between waist circumference and progression of nonalcoholic fatty liver disease (NAFLD) in people with type 2 diabetes. In NAFLD, fat accumulates in the liver,…
